Utama › Kanser Paru-paru › Connecticut › Hartford
Kajian klinikal Kanser Paru-paru di Hartford, CT
11 kajian untuk Kanser Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Hartford (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Mengambil pesertaFasa 3
- Hartford Hospital, Hartford
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi jauh
- dan 1 lagi
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Mengambil pesertaFasa 3
- Hartford Hospital, Hartford
- Hartford HealthCare - Avon, Avon · 8 mi jauh
- Hartford HealthCare - Manchester, Manchester · 8 mi jauh
- dan 1 lagi
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Hartford Hospital, Hartford
Integrated Cancer Repository for Cancer Research
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester · 8 mi jauh
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi jauh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi jauh
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2/3
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi jauh
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Mengambil pesertaFasa 1/2
- Hartford Hospital (site 210), Hartford
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Hartford
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Mengambil pesertaKajian pemerhatian
- Trinity Health Of New England, Hartford
Kajian Kanser Paru-paru di bandar lain
- Houston, TX78 kajian
- Boston, MA62 kajian
- New York City, NY60 kajian
- Los Angeles, CA45 kajian
- Washington, DC41 kajian
- Arlington, VA41 kajian
- Chicago, IL41 kajian
- Nashville, TN40 kajian
- Baltimore, MD40 kajian
- St. Louis, MO39 kajian
- Columbus, OH37 kajian
- Philadelphia, PA36 kajian
Kajian lain di Hartford
- Kanser Paru-paru Bukan Sel Kecil12 kajian
- Gangguan Depresi Major9 kajian
- Kanser (semua jenis)9 kajian
- Kanser Payudara9 kajian
- Neuroblastoma8 kajian
- Mieloma Pelbagai7 kajian
- Kanser Pankreas7 kajian
- Kanser Prostat7 kajian
- Kanser Ovari7 kajian
- Penyakit Kardiovaskular7 kajian
- Kegagalan Jantung7 kajian
- Penyakit Sel Sabit5 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.